Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Drug Safety|August 17, 2000
The value of reporting therapeutic ineffectiveness as an adverse drug reactionR H Meyboom, M Lindquist, A K Flygare, et al.European Journal of Clinical Pharmacology|November 9, 2001
Availability of medicines in the European Union: results from the EURO-Medicines projectP Folino-Gallo, T Walley, J C Frolich, et al.Pharmacoepidemiology and Drug Safety|April 10, 2004
From association to alert--a revised approach to international signal analysisM Lindquist, I R Edwards, A Bate, et al.European Journal of Clinical Pharmacology|January 1, 1992
Pharmacokinetics of pirmenol in young and elderly subjectsD G Ferry, A J Campbell, R Bland, et al.Drug Safety|January 16, 1998
Causal or casual? The role of causality assessment in pharmacovigilanceR H Meyboom, Y A Hekster, A C Egberts, et al.Journal of Chromatography|August 9, 1985
Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatographyL J Schaaf, D G Ferry, C T Hung, et al.Pharmacoepidemiology and Drug Safety|January 1, 1996
Omeprazole and visual disorders: seeing alternativesM Lindquist, M Pettersson, I R Edwards, et al.European Journal of Clinical Pharmacology|August 11, 1998
A Bayesian neural network method for adverse drug reaction signal generationA Bate, M Lindquist, I R Edwards, et al.European Journal of Clinical Pharmacology|January 1, 1990
Enhanced elimination of piroxicam by administration of activated charcoal or cholestyramineD G Ferry, L R Gazeley, W J Busby, et al.Drug Safety|June 1, 1997
Principles of signal detection in pharmacovigilanceR H Meyboom, A C Egberts, I R Edwards, et al.Pageof 7